創薬における人工知能の世界市場インサイト、2029年までの予測

Global Artificial Intelligence in Drug Discovery Market Insights, Forecast to 2029

市場分析と洞察：創薬における人工知能の世界市場創薬における人工知能の世界市場は、予測期間中に30.66%の年間平均成長率（CAGR）で、2023年の17億8676万米ドルから2029年には88億905万米ドルに成長すると予測... もっと見る

出版社	出版年月	電子版価格	言語
QYResearch QYリサーチ	2023年5月4日	US$4,900 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

市場分析と洞察：創薬における人工知能の世界市場
創薬における人工知能の世界市場は、予測期間中に30.66%の年間平均成長率（CAGR）で、2023年の17億8676万米ドルから2029年には88億905万米ドルに成長すると予測されます。
創薬における人工知能の世界の主要企業は、IBM、Google（Alphabet）、Atomwise、Schrodinger、Microsoftなどです。2022年、世界の上位5社の売上高シェアは約18.74%でした。

レポートの内容
本レポートでは、創薬における人工知能の世界市場規模を概観しています。2018年～2022年の過去の市場収益データ、2023年の予測、2029年までのCAGRの予測など、世界市場動向の分析を行っています。
本レポートでは、創薬における人工知能の主要生産者を調査し、主要地域や国の収益も掲載しています。創薬における人工知能の今後の市場可能性のハイライト、およびこの市場を様々なセグメントとサブセグメントに分けて予測するための主要地域/国の注目点。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他諸国の国別データおよび市場価値分析。

本レポートでは、2018年から2023年のデータで、主要企業の創薬における人工知能の収益、市場シェア、業界ランキングに焦点を当てます。世界のArtificial Intelligence in Drug Discovery市場における主要なステークホルダーを特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、関係者が競争環境を理解し、より多くの洞察を得て、自社のビジネスと市場戦略をより良い形で位置づけるのに役立つことでしょう。

本レポートでは、2018年から2029年までの、タイプ別、用途別のセグメントデータ、収益、成長率を分析しています。創薬における人工知能の収益、予測される成長動向、生産技術、アプリケーション、エンドユーザー産業の市場規模を評価・予測します。
IBM Corporation、Microsoft Corporation、Google、NVIDIA Corporation、BPGbio, Inc、Atomwise Inc、Cloud Pharmaceuticals、Insilico Medicine、Aitiaなど、世界の主要プレイヤーの記述的会社プロファイル。

企業別
IBM
エックスサイエンティア
グーグル(Alphabet)
マイクロソフト
アトムワイズ
シュレディンガー
アイティア
インシリコメディスン
エヌビディア
XtalPi
BPGbio
オウキン
サイトー・リージョン
ディープゲノミクス
クラウドファーマシューティカルズ
ベネヴォレントAI
サイリカ
ヴァージ・ゲノミクス
ヴァローヘルス
エンビサジェニックス
エウレトス
バイオエイジラボ
イクトス
バイオサイメトリクス
エバクシオンバイオテック
アリア・ファーマシューティカルズ

タイプ別セグメント
ハードウェア
ソフトウェア
サービス

アプリケーション別セグメント
創薬初期
前臨床試験段階
臨床段階
薬事承認

地域別
北アメリカ
米国
カナダ

アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他

欧州
ドイツ
フランス
英国
イタリア
ロシア
その他のヨーロッパ

ラテンアメリカ
メキシコ
ブラジル
ラテンアメリカのその他

中近東・アフリカ
サウジアラビア
UAE
エジプト
南アフリカ
MEAの残りの地域

各章の概要
第1章：報告書のスコープ、各市場セグメント（製品タイプ、アプリケーションなど）の市場規模、将来の開発可能性などのエグゼクティブサマリーを紹介します。市場の現状と、短中期、長期の展開の可能性を高いレベルで把握することができます。
第2章：創薬における人工知能の世界・地域レベルでの収益。各地域とその主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来の発展見通し、市場スペース、生産能力などを紹介しています。また、市場力学、市場の最新動向、市場の推進要因と制限要因、業界各社が直面する課題とリスク、業界の関連政策の分析などを紹介します。
第3章：創薬における人工知能企業鈥の競争環境、収益、市場シェア、業界ランキング、最新の開発計画、M&A情報などを詳細に分析する。
第4章：各種市場セグメントをタイプ別に分析し、各市場セグメントの収益、発展可能性を網羅し、読者が異なる市場セグメントにおけるブルーオーシャン市場を見つけるのに役立つ情報を提供する。
第5章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの収益、開発可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。
第6章：北米（米国・カナダ）タイプ別、アプリケーション別、国別、各セグメント別の収益。
第7章：ヨーロッパ：タイプ別、アプリケーション別、国別、各セグメント別収益。
第8章：アジア太平洋地域：タイプ別、アプリケーション別、地域別、セグメント別収入
第9章：中南米：タイプ別、アプリケーション別、地域別、セグメント別収益。
第10章中東、アフリカ：タイプ別、アプリケーション別、国別、各セグメント別収益。
第11章：主要企業のプロファイルを提供し、製品の説明や仕様、創薬における人工知能の収益、粗利益率、最近の開発など、市場における主要企業の基本状況を詳細に紹介する。
第12章アナリストの視点/結論

ページTOPに戻る

1 Report Overview 1
1.1 Study Scope 1
1.2 Market Analysis by Type 1
1.2.1 Global Artificial Intelligence in Drug Discovery Market Size Growth Rate by Type: 2018 VS 2023 VS 2029 1
1.2.2 Hardware 3
1.2.3 Software 4
1.2.4 Service 5
1.3 Market by Application 5
1.3.1 Global Artificial Intelligence in Drug Discovery Market Share by Application: 2018 VS 2023 VS 2029 6
1.3.2 Early Drug Discovery 7
1.3.3 Preclinical Phase 8
1.3.4 Clinical Phase 8
1.3.5 Regulatory Approval 8
1.4 Assumptions and Limitations 8
1.5 Study Objectives 9
1.6 Years Considered 10
2 Global Growth Trends 11
2.1 Global Artificial Intelligence in Drug Discovery Market Perspective (2018-2029) 11
2.2 Global Artificial Intelligence in Drug Discovery Growth Trends by Region 12
2.2.1 Global Artificial Intelligence in Drug Discovery Market Size by Region: 2018 VS 2023 VS 2029 13
2.2.2 Artificial Intelligence in Drug Discovery Historic Market Size by Region (2018-2023) 14
2.2.3 Artificial Intelligence in Drug Discovery Forecasted Market Size by Region (2024-2029) 15
2.3 Artificial Intelligence in Drug Discovery Market Dynamics 16
2.3.1 Artificial Intelligence in Drug Discovery Industry Trends 16
2.3.2 Artificial Intelligence in Drug Discovery Market Drivers 17
2.3.3 Artificial Intelligence in Drug Discovery Market Challenges 18
2.3.4 Artificial Intelligence in Drug Discovery Market Restraints 18
3 Competition Landscape by Key Players 19
3.1 Global Revenue Artificial Intelligence in Drug Discovery by Players 19
3.1.1 Global Artificial Intelligence in Drug Discovery Revenue by Players (2018-2023) 19
3.1.2 Global Artificial Intelligence in Drug Discovery Revenue Market Share by Players (2018-2023) 20
3.2 Global Artificial Intelligence in Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 22
3.3 Global Key Players of Artificial Intelligence in Drug Discovery, Ranking by Revenue, 2021 VS 2022 VS 2023 24
3.4 Global Artificial Intelligence in Drug Discovery Market Concentration Ratio 26
3.4.1 Global Artificial Intelligence in Drug Discovery Market Concentration Ratio (CR5 and HHI) 26
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence in Drug Discovery Revenue in 2022 27
3.5 Global Key Players of Artificial Intelligence in Drug Discovery Head office and Area Served 28
3.6 Global Key Players of Artificial Intelligence in Drug Discovery Established Date 29
3.7 Mergers & Acquisitions, Expansion Plans 30
4 Artificial Intelligence in Drug Discovery Breakdown Data by Type 31
4.1 Global Artificial Intelligence in Drug Discovery Historic Market Size by Type (2018-2023) 31
4.2 Global Artificial Intelligence in Drug Discovery Forecasted Market Size by Type (2024-2029) 32
5 Artificial Intelligence in Drug Discovery Breakdown Data by Application 33
5.1 Global Artificial Intelligence in Drug Discovery Historic Market Size by Application (2018-2023) 33
5.2 Global Artificial Intelligence in Drug Discovery Forecasted Market Size by Application (2024-2029) 34
6 North America 35
6.1 North America Artificial Intelligence in Drug Discovery Market Size (2018-2029) 35
6.2 North America Artificial Intelligence in Drug Discovery Market Size by Type 35
6.2.1 North America Artificial Intelligence in Drug Discovery Market Size by Type (2018-2023) 35
6.2.2 North America Artificial Intelligence in Drug Discovery Market Size by Type (2024-2029) 36
6.2.3 North America Artificial Intelligence in Drug Discovery Market Share by Type (2018-2029) 36
6.3 North America Artificial Intelligence in Drug Discovery Market Size by Application 37
6.3.1 North America Artificial Intelligence in Drug Discovery Market Size by Application (2018-2023) 37
6.3.2 North America Artificial Intelligence in Drug Discovery Market Size by Application (2024-2029) 37
6.3.3 North America Artificial Intelligence in Drug Discovery Market Share by Application (2018-2029) 38
6.4 North America Artificial Intelligence in Drug Discovery Market Size by Country 38
6.4.1 North America Artificial Intelligence in Drug Discovery Market Size by Country: 2018 VS 2023 VS 2029 38
6.4.2 North America Artificial Intelligence in Drug Discovery Market Size by Country (2018-2023) 39
6.4.3 North America Artificial Intelligence in Drug Discovery Market Share by Country (2024-2029) 39
6.4.4 United States 40
6.4.5 Canada 41
7 Europe 42
7.1 Europe Artificial Intelligence in Drug Discovery Market Size (2018-2029) 42
7.2 Europe Artificial Intelligence in Drug Discovery Market Size by Type 42
7.2.1 Europe Artificial Intelligence in Drug Discovery Market Size by Type (2018-2023) 42
7.2.2 Europe Artificial Intelligence in Drug Discovery Market Size by Type (2024-2029) 43
7.2.3 Europe Artificial Intelligence in Drug Discovery Market Share by Type (2018-2029) 43
7.3 Europe Artificial Intelligence in Drug Discovery Market Size by Application 44
7.3.1 Europe Artificial Intelligence in Drug Discovery Market Size by Application (2018-2023) 44
7.3.2 Europe Artificial Intelligence in Drug Discovery Market Size by Application (2024-2029) 44
7.3.3 Europe Artificial Intelligence in Drug Discovery Market Share by Application (2018-2029) 45
7.4 Europe Artificial Intelligence in Drug Discovery Market Size by Country 45
7.4.1 Europe Artificial Intelligence in Drug Discovery Market Size by Country: 2018 VS 2023 VS 2029 45
7.4.2 Europe Artificial Intelligence in Drug Discovery Market Size by Country (2018-2023) 46
7.4.3 Europe Artificial Intelligence in Drug Discovery Market Size by Country (2024-2029) 46
7.4.4 Germany 48
7.4.5 France 48
7.4.6 U.K. 49
7.4.7 Italy 49
7.4.8 Russia 50
8 Asia-Pacific 51
8.1 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size (2018-2029) 51
8.2 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Type 51
8.2.1 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Type (2018-2023) 51
8.2.2 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Type (2024-2029) 52
8.2.3 Asia-Pacific Artificial Intelligence in Drug Discovery Market Share by Type (2018-2029) 52
8.3 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Application 53
8.3.1 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Application (2018-2023) 53
8.3.2 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Application (2024-2029) 53
8.3.3 Asia-Pacific Artificial Intelligence in Drug Discovery Market Share by Application (2018-2029) 54
8.4 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Region 54
8.4.1 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Region: 2018 VS 2023 VS 2029 54
8.4.2 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Region (2018-2023) 55
8.4.3 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Region (2024-2029) 55
8.4.4 China 57
8.4.5 Japan 57
8.4.6 South Korea 58
8.4.7 Southeast Asia 58
8.4.8 India 59
8.4.9 Australia 59
9 Latin America 61
9.1 Latin America Artificial Intelligence in Drug Discovery Market Size (2018-2029) 61
9.2 Latin America Artificial Intelligence in Drug Discovery Market Size by Type 61
9.2.1 Latin America Artificial Intelligence in Drug Discovery Market Size by Type (2018-2023) 61
9.2.2 Latin America Artificial Intelligence in Drug Discovery Market Size by Type (2024-2029) 62
9.2.3 Latin America Artificial Intelligence in Drug Discovery Market Share by Type (2018-2029) 62
9.3 Latin America Artificial Intelligence in Drug Discovery Market Size by Application 63
9.3.1 Latin America Artificial Intelligence in Drug Discovery Market Size by Application (2018-2023) 63
9.3.2 Latin America Artificial Intelligence in Drug Discovery Market Size by Application (2024-2029) 63
9.3.3 Latin America Artificial Intelligence in Drug Discovery Market Share by Application (2018-2029) 64
9.4 Latin America Artificial Intelligence in Drug Discovery Market Size by Country 64
9.4.1 Latin America Artificial Intelligence in Drug Discovery Market Size by Country: 2018 VS 2023 VS 2029 64
9.4.2 Latin America Artificial Intelligence in Drug Discovery Market Size by Country (2018-2023) 65
9.4.3 Latin America Artificial Intelligence in Drug Discovery Market Size by Country (2024-2029) 65
9.4.4 Mexico 66
9.4.5 Brazil 67
10 Middle East, Africa 68
10.1 Middle East, Africa Artificial Intelligence in Drug Discovery Market Size (2018-2029) 68
10.2 Middle East, Africa Artificial Intelligence in Drug Discovery Market Size by Type 68
10.2.1 Middle East, Africa Artificial Intelligence in Drug Discovery Market Size by Type (2018-2023) 68
10.2.2 Middle East, Africa Artificial Intelligence in Drug Discovery Market Size by Type (2024-2029) 69
10.2.3 Middle East, Africa Artificial Intelligence in Drug Discovery Market Share by Type (2018-2029) 69
10.3 Middle East, Africa Artificial Intelligence in Drug Discovery Market Size by Application 70
10.3.1 Middle East, Africa Artificial Intelligence in Drug Discovery Market Size by Application (2018-2023) 70
10.3.2 Middle East, Africa Artificial Intelligence in Drug Discovery Market Size by Application (2024-2029) 70
10.3.3 Middle East, Africa Artificial Intelligence in Drug Discovery Market Share by Application (2018-2029) 71
10.4 Middle East, Africa Artificial Intelligence in Drug Discovery Market Size by Country 71
10.4.1 Middle East, Africa Artificial Intelligence in Drug Discovery Market Size by Country: 2018 VS 2023 VS 2029 71
10.4.2 Middle East, Africa Artificial Intelligence in Drug Discovery Market Size by Country (2018-2023) 72
10.4.3 Middle East, Africa Artificial Intelligence in Drug Discovery Market Size by Country (2024-2029) 72
10.4.4 Saudi Arabia 73
10.4.5 UAE 74
10.4.6 Egypt 74
10.4.7 South Africa 75
11 Key Players Profiles 76
11.1 IBM Corporation 76
11.1.1 IBM Corporation Company Details 76
11.1.2 IBM Corporation Business Overview 76
11.1.3 IBM Corporation Artificial Intelligence in Drug Discovery Introduction 77
11.1.4 IBM Corporation Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 79
11.1.5 IBM Corporation Recent Development 79
11.2 Exscientia 80
11.2.1 Exscientia Company Details 80
11.2.2 Exscientia Business Overview 81
11.2.3 Exscientia Artificial Intelligence in Drug Discovery Introduction 81
11.2.4 Exscientia Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 82
11.2.5 Exscientia Recent Development 82
11.3 Google (Alphabet) 83
11.3.1 Google (Alphabet) Company Details 83
11.3.2 Google (Alphabet) Business Overview 84
11.3.3 Google (Alphabet) Artificial Intelligence in Drug Discovery Introduction 84
11.3.4 Google (Alphabet) Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 85
11.3.5 Google (Alphabet) Recent Development 85
11.4 Microsoft Corporation 86
11.4.1 Microsoft Corporation Company Details 86
11.4.2 Microsoft Corporation Business Overview 86
11.4.3 Microsoft Corporation Artificial Intelligence in Drug Discovery Introduction 87
11.4.4 Microsoft Corporation Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 89
11.4.5 Microsoft Corporation Recent Development 89
11.5 Atomwise Inc 90
11.5.1 Atomwise Inc Company Details 90
11.5.2 Atomwise Inc Business Overview 90
11.5.3 Atomwise Inc Artificial Intelligence in Drug Discovery Introduction 91
11.5.4 Atomwise Inc Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 92
11.5.5 Atomwise Inc Recent Development 92
11.6 Schrodinger 93
11.6.1 Schrodinger Company Details 93
11.6.2 Schrodinger Business Overview 93
11.6.3 Schrodinger Artificial Intelligence in Drug Discovery Introduction 94
11.6.4 Schrodinger Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 95
11.6.5 Schrodinger Recent Development 96
11.7 Aitia 97
11.7.1 Aitia Company Details 97
11.7.2 Aitia Business Overview 97
11.7.3 Aitia Artificial Intelligence in Drug Discovery Introduction 98
11.7.4 Aitia Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 98
11.7.5 Aitia Recent Development 99
11.8 Insilico Medicine 100
11.8.1 Insilico Medicine Company Details 100
11.8.2 Insilico Medicine Business Overview 100
11.8.3 Insilico Medicine Artificial Intelligence in Drug Discovery Introduction 101
11.8.4 Insilico Medicine Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 102
11.8.5 Insilico Medicine Recent Development 102
11.9 NVIDIA Corporation 103
11.9.1 NVIDIA Corporation Company Details 103
11.9.2 NVIDIA Corporation Business Overview 103
11.9.3 NVIDIA Corporation Artificial Intelligence in Drug Discovery Introduction 104
11.9.4 NVIDIA Corporation Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 105
11.9.5 NVIDIA Corporation Recent Development 105
11.10 XtalPi 106
11.10.1 XtalPi Company Details 106
11.10.2 XtalPi Business Overview 106
11.10.3 XtalPi Artificial Intelligence in Drug Discovery Introduction 107
11.10.4 XtalPi Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 108
11.10.5 XtalPi Recent Development 108
11.11 BPGbio, Inc 109
11.11.1 BPGbio, Inc Company Details 109
11.11.2 BPGbio, Inc Business Overview 109
11.11.3 BPGbio, Inc Artificial Intelligence in Drug Discovery Introduction 110
11.11.4 BPGbio, Inc Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 110
11.11.5 BPGbio, Inc Recent Development 111
11.12 Owkin Inc 112
11.12.1 Owkin Inc Company Details 112
11.12.2 Owkin Inc Business Overview 112
11.12.3 Owkin Inc Artificial Intelligence in Drug Discovery Introduction 113
11.12.4 Owkin Inc Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 113
11.12.5 Owkin Inc Recent Development 114
11.13 CytoReason 115
11.13.1 CytoReason Company Details 115
11.13.2 CytoReason Business Overview 115
11.13.3 CytoReason Artificial Intelligence in Drug Discovery Introduction 116
11.13.4 CytoReason Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 116
11.13.5 CytoReason Recent Development 117
11.14 Deep Genomics 117
11.14.1 Deep Genomics Company Details 117
11.14.2 Deep Genomics Business Overview 118
11.14.3 Deep Genomics Artificial Intelligence in Drug Discovery Introduction 118
11.14.4 Deep Genomics Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 119
11.14.5 Deep Genomics Recent Development 120
11.15 Cloud Pharmaceuticals 121
11.15.1 Cloud Pharmaceuticals Company Details 121
11.15.2 Cloud Pharmaceuticals Business Overview 121
11.15.3 Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Introduction 121
11.15.4 Cloud Pharmaceuticals Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 122
11.15.5 Cloud Pharmaceuticals Recent Development 123
11.16 BenevolentAI 123
11.16.1 BenevolentAI Company Details 123
11.16.2 BenevolentAI Business Overview 124
11.16.3 BenevolentAI Artificial Intelligence in Drug Discovery Introduction 124
11.16.4 BenevolentAI Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 125
11.16.5 BenevolentAI Recent Development 126
11.17 Cyclica 127
11.17.1 Cyclica Company Details 127
11.17.2 Cyclica Business Overview 128
11.17.3 Cyclica Artificial Intelligence in Drug Discovery Introduction 128
11.17.4 Cyclica Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 129
11.17.5 Cyclica Recent Development 129
11.18 Verge Genomics 130
11.18.1 Verge Genomics Company Details 130
11.18.2 Verge Genomics Business Overview 130
11.18.3 Verge Genomics Artificial Intelligence in Drug Discovery Introduction 131
11.18.4 Verge Genomics Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 132
11.18.5 Verge Genomics Recent Development 133
11.19 Valo Health 134
11.19.1 Valo Health Company Details 134
11.19.2 Valo Health Business Overview 134
11.19.3 Valo Health Artificial Intelligence in Drug Discovery Introduction 135
11.19.4 Valo Health Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 135
11.19.5 Valo Health Recent Development 136
11.20 Envisagenics 137
11.20.1 Envisagenics Company Details 137
11.20.2 Envisagenics Business Overview 137
11.20.3 Envisagenics Artificial Intelligence in Drug Discovery Introduction 138
11.20.4 Envisagenics Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 138
11.20.5 Envisagenics Recent Development 139
11.21 Euretos 140
11.21.1 Euretos Company Details 140
11.21.2 Euretos Business Overview 140
11.21.3 Euretos Artificial Intelligence in Drug Discovery Introduction 141
11.21.4 Euretos Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 141
11.21.5 Euretos Recent Development 142
11.22 BioAge Labs 143
11.22.1 BioAge Labs Company Details 143
11.22.2 BioAge Labs Business Overview 143
11.22.3 BioAge Labs Artificial Intelligence in Drug Discovery Introduction 144
11.22.4 BioAge Labs Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 144
11.22.5 BioAge Labs Recent Development 145
11.23 Iktos 146
11.23.1 Iktos Company Details 146
11.23.2 Iktos Business Overview 146
11.23.3 Iktos Artificial Intelligence in Drug Discovery Introduction 147
11.23.4 Iktos Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 148
11.23.5 Iktos Recent Development 148
11.24 BioSymetrics 149
11.24.1 BioSymetrics Company Details 149
11.24.2 BioSymetrics Business Overview 149
11.24.3 BioSymetrics Artificial Intelligence in Drug Discovery Introduction 150
11.24.4 BioSymetrics Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 150
11.24.5 BioSymetrics Recent Development 151
11.25 Evaxion Biotech A/S 152
11.25.1 Evaxion Biotech A/S Company Details 152
11.25.2 Evaxion Biotech A/S Business Overview 152
11.25.3 Evaxion Biotech A/S Artificial Intelligence in Drug Discovery Introduction 153
11.25.4 Evaxion Biotech A/S Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 153
11.25.5 Evaxion Biotech A/S Recent Development 154
11.26 Aria Pharmaceuticals, Inc 155
11.26.1 Aria Pharmaceuticals, Inc Company Details 155
11.26.2 Aria Pharmaceuticals, Inc Business Overview 155
11.26.3 Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Introduction 156
11.26.4 Aria Pharmaceuticals, Inc Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023) 156
11.26.5 Aria Pharmaceuticals, Inc Recent Development 157
12 Analyst's Viewpoints/Conclusions 158
13 Appendix 160
13.1 Research Methodology 160
13.1.1 Methodology/Research Approach 160
13.1.2 Data Source 163
13.2 Author Details 166
13.3 Disclaimer 168

ページTOPに戻る

Table of Contents

Summary

Market Analysis and Insights: Global Artificial Intelligence in Drug Discovery Market
The global Artificial Intelligence in Drug Discovery market is projected to grow from US$ 1,786.76 million in 2023 to US$ 8,890.05 million by 2029, at a Compound Annual Growth Rate (CAGR) of 30.66% during the forecast period.
The global key companies of Artificial Intelligence in Drug Discovery include IBM, Google (Alphabet), Atomwise, Schrodinger and Microsoft, etc. In 2022, the global top five players had a share approximately 18.74% in terms of revenue.

Report Includes
This report presents an overview of global market for Artificial Intelligence in Drug Discovery market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Artificial Intelligence in Drug Discovery, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Artificial Intelligence in Drug Discovery, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Artificial Intelligence in Drug Discovery revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Artificial Intelligence in Drug Discovery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Artificial Intelligence in Drug Discovery revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including IBM Corporation, Microsoft Corporation, Google, NVIDIA Corporation, BPGbio, Inc, Atomwise Inc, Cloud Pharmaceuticals, Insilico Medicine, and Aitia, etc.

By Company
IBM
Exscientia
Google (Alphabet)
Microsoft
Atomwise
Schrodinger
Aitia
Insilico Medicine
NVIDIA
XtalPi
BPGbio
Owkin
CytoReason
Deep Genomics
Cloud Pharmaceuticals
BenevolentAI
Cyclica
Verge Genomics
Valo Health
Envisagenics
Euretos
BioAge Labs
Iktos
BioSymetrics
Evaxion Biotech
Aria Pharmaceuticals

Segment by Type
Hardware
Software
Service

Segment by Application
Early Drug Discovery
Preclinical Phase
Clinical Phase
Regulatory Approval

By Region
North America
United States
Canada

Asia-Pacific-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Others

Europe
Germany
France
UK
Italy
Russia
Rest of Europe

Latin America
Mexico
Brazil
Rest of Latin America

Middle East & Africa
Saudi Arabia
UAE
Egypt
South Africa
Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Artificial Intelligence in Drug Discovery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence in Drug Discovery companies鈥 competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: Asia-Pacific by Type, by Application and by region, revenue for each segment.
Chapter 9: Latin America by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Intelligence in Drug Discovery revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（金融）の最新刊レポート

QYResearch 社の最新刊レポート

本レポートと同じKEY WORD（artificial intelligence）の最新刊レポート

よくあるご質問

QYResearch社はどのような調査会社ですか?

QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

創薬における人工知能の世界市場インサイト、2029年までの予測

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（金融）の最新刊レポート

QYResearch 社の最新刊レポート

本レポートと同じKEY WORD（artificial intelligence）の最新刊レポート

よくあるご質問

QYResearch社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?